PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $97.86 Average Price Target from Analysts
PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year target price among […]
PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year target price among […]
